CT-388
Enith-MACE
Roche · Phase 3 · Not yet recruiting · Enrollment 8200
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Arm 1: Placebo | n/r | n/r | n/r | n/r | n/r |
| Arm 2: Enicepatide | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.